Data_Sheet_1_Education, Altitude, and Humidity Can Interactively Explain Spatial Discrepancy and Predict Short Stature in 213,795 Chinese School Children.DOC by Jia Ma (438820)

“…</p><p>Methods: Data on the prevalence of short stature were obtained from a 2014 cross-sectional survey of China (CNSSCH). …”

Data_Sheet_1_The Effect of Qiweibaizhu Powder Crude Polysaccharide on Antibiotic-Associated Diarrhea Mice Is Associated With Restoring Intestinal Mucosal Bacteria.zip by Cuiru Li (13017129)

“…In the PCA and PCoA, the mn and ma group samples were both relatively concentrated with a high similarity of community structure. …”

Data_Sheet_4_The Effect of Qiweibaizhu Powder Crude Polysaccharide on Antibiotic-Associated Diarrhea Mice Is Associated With Restoring Intestinal Mucosal Bacteria.zip by Cuiru Li (13017129)

“…In the PCA and PCoA, the mn and ma group samples were both relatively concentrated with a high similarity of community structure. …”

Table_3_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With... by Yoon Ji Kim (136886)

“…HbA1c level in the insulin+sotagliflozin group was significantly lower than that in the insulin alone group (mean difference: −0.43, 95% credible interval: −0.62 to −0.23). …”

Image_7_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With... by Yoon Ji Kim (136886)

“…HbA1c level in the insulin+sotagliflozin group was significantly lower than that in the insulin alone group (mean difference: −0.43, 95% credible interval: −0.62 to −0.23). …”

Table_2_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With... by Yoon Ji Kim (136886)

“…HbA1c level in the insulin+sotagliflozin group was significantly lower than that in the insulin alone group (mean difference: −0.43, 95% credible interval: −0.62 to −0.23). …”

Image_1_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With... by Yoon Ji Kim (136886)

“…HbA1c level in the insulin+sotagliflozin group was significantly lower than that in the insulin alone group (mean difference: −0.43, 95% credible interval: −0.62 to −0.23). …”

Image_8_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With... by Yoon Ji Kim (136886)

“…HbA1c level in the insulin+sotagliflozin group was significantly lower than that in the insulin alone group (mean difference: −0.43, 95% credible interval: −0.62 to −0.23). …”

Image_4_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With... by Yoon Ji Kim (136886)

“…HbA1c level in the insulin+sotagliflozin group was significantly lower than that in the insulin alone group (mean difference: −0.43, 95% credible interval: −0.62 to −0.23). …”

Image_6_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With... by Yoon Ji Kim (136886)

“…HbA1c level in the insulin+sotagliflozin group was significantly lower than that in the insulin alone group (mean difference: −0.43, 95% credible interval: −0.62 to −0.23). …”

Image_2_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With... by Yoon Ji Kim (136886)

“…HbA1c level in the insulin+sotagliflozin group was significantly lower than that in the insulin alone group (mean difference: −0.43, 95% credible interval: −0.62 to −0.23). …”

Image_9_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With... by Yoon Ji Kim (136886)

“…HbA1c level in the insulin+sotagliflozin group was significantly lower than that in the insulin alone group (mean difference: −0.43, 95% credible interval: −0.62 to −0.23). …”

Image_5_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With... by Yoon Ji Kim (136886)

“…HbA1c level in the insulin+sotagliflozin group was significantly lower than that in the insulin alone group (mean difference: −0.43, 95% credible interval: −0.62 to −0.23). …”

Image_3_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With... by Yoon Ji Kim (136886)

“…HbA1c level in the insulin+sotagliflozin group was significantly lower than that in the insulin alone group (mean difference: −0.43, 95% credible interval: −0.62 to −0.23). …”

Table_1_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With... by Yoon Ji Kim (136886)

“…HbA1c level in the insulin+sotagliflozin group was significantly lower than that in the insulin alone group (mean difference: −0.43, 95% credible interval: −0.62 to −0.23). …”

Data_Sheet_1_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients... by Yoon Ji Kim (136886)

“…HbA1c level in the insulin+sotagliflozin group was significantly lower than that in the insulin alone group (mean difference: −0.43, 95% credible interval: −0.62 to −0.23). …”

Mobile Epifauna Associated To Artificial Substrates In Offshore Qatari Waters by Abdulaziz Aziz, Naeem

“…Multivariate analysis for abundance and biomass showed that both Site and Depth, as well as their interaction, had significant effects on the mobile macrofaunal community. A general trend of total abundance and average number of taxa decreasing with depth was observed, although with some notable exceptions. …”
Get full text

Image_7_Temporal Bacterial Community Diversity in the Nicotiana tabacum Rhizosphere Over Years of Continuous Monocropping.TIF by Lang Yan (532266)

“…In this study, high-throughput sequencing targeting the 16S rRNA gene phylogenetic marker was performed on 60 soil samples of rhizosphere soil from flue−cured tobacco in the replanting, growth and harvest period across 5, 10, and 20 years of a continuous monocropping system. Bacterial community diversity decreased with the increase in duration of continuous monocropping, and the rhizosphere microbiota was highly dynamic in the harvest period. …”

Image_4_Effect of Ocean Acidification on Bacterial Metabolic Activity and Community Composition in Oligotrophic Oceans, Inferred From Short-Term Bioassays.TIF by Caiqin Hu (9948616)

“…OA mitigated bacterial growth efficiency, and consequently, a larger fraction of DOC entering microbial loops was transferred to CO₂.…”

Image_6_Glucose Metabolites Exert Opposing Roles in Tumor Chemoresistance.TIF by Chung-Yen Huang (7902398)

“…Our finding argues against ATP as the main effector for glucose-mediated chemoresistance and supports a key role of glycolytic pyruvate as an antioxidant for dual modes of action: necroptosis reduction and a cell cycle shift to a quiescent state.…”